Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy

Not Applicable

Completed

• Conditions: Cervicitis; CIN; Cancer of Cervix
• Interventions: Procedure: Cervical biopsy

• Registration Number: NCT04809727
• Lead Sponsor: Tanta University

Brief Summary

Supracervical hysterectomy is widely common and had many complications either immediate or delayed. In these patients bleeding, infection, chronic pelvic pain are common. In these patients cervical biopsy was done and histopathological examinations were done to evaluate the pathology in these patients.

Detailed Description

* Study design and settings: Cross sectional descriptive studies conducted from December 2017 till January 2021.

* Patients: 80 patients with supracervical hysterectomy recruited at Tanta University Hospital, gynecology clinics will be recruited according inclusion and exclusion criteria. Inclusion criteria include all symptomatizing patients following supracervical hysterectomy, of any age, of any complaints. The exclusion criteria were patients with total hysterectomy, hysterectomies for malignant indications, and refusal to participate.

* Methods: All patients' demographic data, history, indication of hysterectomy, duration since operation, postoperative complications and their main complaint.

Intervention: under general anesthesia cervical biopsy (4 quadrants) were taken from all patients and was sent for histopathological examinations.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2017-12-01
• Primary Completion: 2020-12-31
• Study Completion: 2021-01-31
• Study First Submitted: 2021-03-13
• Study First Submitted QC: 2021-03-18
• Study First Posted: 2021-03-22
• Status Verified: 2021-04
• Last Update Submitted: 2021-04-04
• Last Update Posted: 2021-04-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 88

Inclusion Criteria

• all symptomatizing patients following supracervical hysterectomy,

Read More

Exclusion Criteria

• with total hysterectomy,
• hysterectomies for malignant indications,
• refusal to participate.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Biopsy	Cervical biopsy	four quadrant biopsy

Primary Outcome Measures

Name	Time	Method
Detection of chronic cervicitis incidence	1 year	Detection of number of cases diagnosed with inflammatory cells and other markers of inflammation
Detection of cervical neoplasia or cancer incidence	1 year	Detection of number of cases diagnosed with cervical Cervical intraepithelial neoplasia, or malignancy by histopathological examination

Trial Locations

Locations (1)

Ayman Shehata Dawood; 🇪🇬 Tanta, Gharbia, Egypt